DNA as a target for drug action

Laurence H. Hurley, F. Leslie Boyd

Research output: Contribution to journalReview articlepeer-review

95 Scopus citations


DNA is the presumed target for a number of clinically useful anticancer drugs. In this review, Laurence Hurley and Leslie Boyd discuss the appropriateness of the term 'receptor' for DNA and outline the forseeable problems in designing drugs that will produce a defined pharmacological response through interaction with DNA. They describe the structural features which present DNA as an attractive target for drug design, and the possible characteristics of drugs that react with DNA to produce a predetermined biochemical response. Finally, they outline modern approaches to elucidating the structural and biological consequences of drug modification.

Original languageEnglish (US)
Pages (from-to)402-407
Number of pages6
JournalTrends in Pharmacological Sciences
Issue number11
StatePublished - Nov 1988

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'DNA as a target for drug action'. Together they form a unique fingerprint.

Cite this